Kymera Therapeutics

Kymera Therapeutics to Present at Upcoming March Investor Conferences

WATERTOWN, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will participate in upcoming investor